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CHARACTERIZATION OF PG1604 (PorZ) AS AN ESSENTIAL COMPONENT OF 
TYPE 9 SECRETION SYSTEM IN PORPHYROMONAS GINGIVALIS 
 
Apurva Tadimari Prabhakar 
 
July 14, 2016 
 
 
Background: The numerous virulence factors of Porphyromonas gingivalis are essential 
for the organism to invade host tissues while escaping immune responses [1, 2]. Some of 
these factors, like major proteases referred to as gingipains, are secreted by a unique 
secretion system called PerioGate or Type IX Secretion System (T9SS). T9SS consists of 
a number of membrane and periplasmic proteins, which provide transportation only for 
proteins that possess a conserved C-terminal domain (CTD). The CTD functions as a 
specific recognition signal for the T9SS. PG1604 of P. gingivalis W83 is a CTD-containing 
protein, which has been shown in our initial studies to be essential for secretion of CTD-
proteins. However, unlike other CTD proteins, PorZ was also shown by proteomic studies 
to be present in the wild-type strain as the full-length protein containing the CTD domain 
(minus a signal peptide) [3, 4]. 
Objectives: Our objective was to probe structure-function relationship of the PG1604 
protein by insertions of an oligohistidine motif or substitutions of six consecutive residues 
with hexahistidine within the C-terminal domain of PG1604. Effects of these mutations 
were monitored by various phenotypic tests and allowed to assess their influence on 
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PG1604 maturation and function. Methods: 1) Oligohistidine insertions into the PG1604 
protein by plasmid-based SLIM mutagenesis. 2) Generation of a P. gingivalis mutant strain 
expressing the modified PG1604 from the chromosome. 3) Phenotype analysis conducted 
on the whole set of the CTD altered PG1604, including the strain obtained in this study 
(AT001). Assays included: a) assessment of colony pigmentation on blood agar plates, b) 
the gingipains activity assay, c) western-blot analysis to detect the presence and subcellular 
localization of PG1604 (anti-PG1604 and anti-HIS tag antibodies) as well as the presence 
and processing of the Kgp and Rgp proteins. Results: 1) Some mutants showed the altered 
secretory phenotype detected by the strains failure to form pigmented colonies on the blood 
agar plate. 2) The lack of pigmentation correlated with severely decreased gingipains 
activities and with changes in proKgp and proRgp protein posttranslational processing 
visualized by western-blot. 4) The PG1604 protein was found to be localized mainly in the 
outer membrane. 5) HIS-tagged PG1604 may be purified from P. gingivalis culture for 
further analysis. Conclusions: 1) The CTD of the PG1604 protein is not cleaved off upon 
its transport through T9SS as full length ~80 kDa protein was shown by western-blot 
analysis with anti-PG1604 serum (migration at) and anti-HIS mAb for the PG1604 variant 
tagged with octahistidine at the C-terminus (P. gingivalis strain DM008). 2) The selective 
modifications of the PG1604 protein, hindered the proper maturation of secreted virulence 
factors (Kgp and Rgp) due to disrupted function of T9SS in P. gingivalis. Taken together 
based on our findings we concluded that PG1604 is a novel functional component of 
T9SS located on the bacterial surface in association with the outer membrane. The 
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CTD of PG1604 is not only essential for translocation across the OM but also for this 
protein function in other CTD-proteins secretion and their posttranslational 
modifications (A-LPS attachment and proteolytic processing). Therefore, following 
the nomenclature of the T9SS components we designate the PG1604 protein as PorZ. 
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Periodontitis is one of the most prevalent chronic inflammatory diseases that leads 
to loss of the integrity of periodontium, which is comprised of gingiva, periodontal 
ligament, and alveolar bone [5]. It is considered as the foremost cause of teeth loss and is 
said to be involved in the development and also the progression of many systemic problems 
such as rheumatoid arthritis, atherosclerosis, adverse pregnancy outcomes, aspiration 
pneumonia and cancer [6]. Recent studies indicate that in US adult population, periodontal 
disease is quite prevalent with approximately 90% exhibiting at least some form of 
gingivitis and 47% of the population with periodontitis; with the severe form of 
periodontitis affecting 18% of those individuals over the age of 65 [7-9]. For individuals 
and societies, the cost of the treatment is expensive, consuming between 5 and 10% of all 
healthcare resources [10].  
Epidemiologically, studies have shown that poor oral hygiene is associated with 
more severe disease, but chronic plaque accumulation is not the only predictor of the 
disease. Other factors such as smoking and systemic problems like diabetes, cardiovascular 







 Host-microbe interplay in periodontitis and other risk factors  
Studies show the human microbiome play an important role in the overall 
health of the human host. Characterizing the different microbial communities 
colonizing the human body sites like skin, gut,etc., has been of utmost importance [13, 
14]. The oral cavity represents one of the most diverse microbial communities 
associated with any of the human sites studied. It comprises of a highly complex 
community with around 700 species identified to be associated with the different 
environments within the oral cavity. It is probably one of the best characterized 
communities of the human microbiome [15]. Polymicrobial synergy is seen among 
the organisms which form these communities in oral cavity maintaining the tissue 
homeostasis and normal immune responses. In periodontal disease, the shift from 
healthy tissue to diseased is associated with a drastic change from a symbiotic microbial 
community (Figure 1), comprising mostly of facultative bacterial genera such 
as Streptococci and Actinomyces, to a dysbiotic microbial community structure made up of 
mainly anaerobic genera from the phyla Proteobacteria, Bacteroidetes, Spirochaetes 
and Synergistetes, leading to a dysregulated host immune response. The dysbiotic oral 
microbiota encompassing many pathogenic species can thrive in an inflammatory 





Figure 1. Polymicrobial synergy and dysbiosis in periodontitis  
In a predisposed individual, periodontitis is induced by a polymicrobial community which 
is comprised of distinct organisms playing different roles. Keystone pathogens along with 
accessory pathogens, destabilize the host immune response causing microbial dysbiosis 
due to immune system over-activation leading to periodontal tissue destruction. The lower 
part of the figure depicts the progression of healthy periodontium to gingivitis (periodontal 
inflammation without bone loss; gingival crevice ≤3 mm) to periodontitis (formation of 
periodontal pockets ≥4 mm and inflammatory bone loss). Adapted from Nat Rev Immunol. 





The etiology of periodontitis is not just limited to the dysbiotic microbial 
community. It involves other independent but modifiable risk factors which include 
lifestyle factors, such as smoking and alcohol consumption. It also includes diseases and 
unhealthy conditions such as diabetes mellitus, obesity, metabolic syndrome, osteoporosis, 
and low dietary calcium and vitamin D. These diseases might cause a reduction in the 
number or function of polymorphonuclear leukocytes (PMNs), which in turn can result in 
an increased rate and severity of periodontal destruction [17]. Genetic factors also play a 
role in periodontal disease, which can be a target for individualized prevention and early 
detection [18, 19].  
 
Role of Porphyromonas gingivalis in periodontal disease 
P. gingivalis, a Gram-negative oral anaerobe which belongs to the phylum 
Bacteroidetes, is considered to be one of the keystone pathogens of the periodontal disease 
[20]. P. gingivalis not only alters the growth and development of the entire biofilm but 
disturb the normal homeostatic host-microbe interaction in the periodontium. It was found 
in 85.75% of subgingival plaque samples from patients with chronic periodontitis. P. 
gingivalis can locally invade periodontal tissues and evade the host defense mechanisms. 
It utilizes a panel of virulence factors that cause deregulation of the innate immune and 





Figure 2. P. gingivalis-induced dysbiosis and periodontal disease. 
Studies have shown that P. gingivalis modulates innate host defense functions that can 
have a general effect on the oral commensal community. Immune subversion of IL-8 
secretion, complement activity, or TLR4 activation can cause an impaired host defense. 
The host loses its ability to control the oral commensal microbial community leading to an 
altered oral microbial composition and an increased microbial load. This change from a 
symbiotic to a dysbiotic microbiota is the cause for pathologic inflammation and bone loss. 




P. gingivalis is a non-motile, asaccharolytic bacterium, an obligatory anaerobic rod 
which forms black-pigmented colonies on blood agar plates due to an absolute requirement 



















The major habitat of P. gingivalis is the subgingival sulcus of the human oral 
cavity. It depends on the fermentation of amino acids for energy production, a property 
required for its survival in the deep periodontal pocket, where sugar availability is low. 
Being an obligate anaerobe [24], P. gingivalis is the secondary colonizer of dental plaque, 
often adhering to primary colonizers such as Streptococcus gordonii and P. intermedia 
[21].        
P. gingivalis is known to produce an array of virulence factors that could penetrate 
the gingivae and cause tissue destruction directly or indirectly, by induction of 
inflammation [25]. In order to survive and multiply in a host, P. gingivalis has to evade the 
Figure 3. Black-pigmented culture of periodontopathogen P. gingivalis on 
blood agar. The pigmentation is due to accumulation of hemin (oxidized form 
of heme) on the cell surface when grown on blood agar. Studies show that 
gingipain are also involved in hemoglobin degradation and acquisition of heme 






host external protective barriers before it could find a suitable ecological niche for 
colonization. Colonization happens in the presence of virulence factors such as fimbriae, 
capsules, lipopolysaccharide (LPS), lipoteichoic acids, haemagglutinins, gingipains, outer 








Figure 4. Virulence factors of P. gingivalis (Adapted from The Prokaryotes 2006,   
pp 428-454) 
 
Outer membrane vesicles (OMVs) of P. gingivalis contain virulence factors such 
as lipopolysaccharide and gingipains [27]. Lipopolysaccharide circulates systemically in 
over 50% of periodontal disease patients and is associated with increased matrix 
metalloproteinase [28]. The gingipain-laden outer membrane vesicles may contribute to 
tissue destruction in periodontal diseases by serving as a vehicle for the antigens and active 
proteases [29]. Gingipains are the cysteine proteinases secreted by P. gingivalis and are 
considered the major virulence factors involved in periodontal pathogenesis [30]. 
Gingipains comprise of Arg-specific cysteine proteinases (Rgp) encoded 





Table 1. The virulence factors and host effectors produced by P. gingivalis [25] 
 
 
Protein secretion system in P. gingivalis:  
In Gram-negative bacteria, protein secretion across two lipid bilayers: the cell 
membrane (the inner membrane; IM) and the outer membrane (OM), is a logistical 
challenge.  To achieve this, Gram-negative bacteria have evolved nine known Types (I to 
IX) of Secretion Systems (TxSS) to translocate proteins synthesized in the cytoplasm to 
the bacterial surface and beyond [32]. Using specific systems, bacteria are able to assemble 
cell surface appendages such as pili (T2SS, T4SS, T7SS), curli (T8SS), flagellum (T3SS), 
secrete proteins extracellularly (T1SS to T6SS) or inject them directly into a host 
eukaryotic cell (T3SS and T4SS) or into the periplasm of other bacteria (T6SS) [33].  The 
proteins to be translocated are either secreted directly from the cytoplasm via T1SS, T3SS, 
T4SS and T6SS or they are first exported to the periplasm across the IM using the 
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conserved Sec or Tat pathway and then translocated through the OM using T2SS, T5SS, 
T7SS or T8SS [34].   
The most recently discovered system, T9SS, formerly designated the Por secretion 
system (PorSS), operate in selected bacterial species belonging exclusively to the 
Bacteroidetes phylum, including periodontal pathogens (P. gingivalis and Tannerella 
forsythia) and a number of environmental benign microorganisms [35]. T9SS is essential 
for the secretion of many proteinaceous virulence factors by the periodontal pathogens 
[36], and thus, has attracted considerable attention as a possible target for pharmaceutical 
intervention. The system is also required for assembly of the gliding motility machinery of 
a number of environmental microorganisms such as Cytophaga hutchinsonii and 
Flavobacterium johnsoniae [35].  
All cargo proteins of T9SS contain a conserved C-terminal domain (CTD) of 
approximately 70 amino acid residues with an immunoglobulin-like fold [37].  With a few 
exceptions, these proteins carry a typical cleavable signal peptide and are apparently 
exported to the periplasm using the Sec system to cross the IM [38]. In the periplasm, T9SS 
cargo proteins fold and then are directed to an OM translocon by a targeting signal located 
in the last two β-strand of the CTD [34, 39].  During the translocation, the CTD is cleaved 
off and the protein is released extracellularly [3] (Figure 5). At least in P. gingivalis, the 
CTD cleavage occurs seemingly simultaneously with the covalent attachment of anionic 
lipopolysaccharide (A-LPS) to the newly released C-terminal carbonyl group of the 
truncated protein [40].  The A-LPS attachment serves to anchor the secreted proteins to the 
OM where they form an electron dense surface layer (EDSL) characteristic for P. gingivalis 




Figure 5. Model of the T9SS (Type IX Secretion System) of P. gingivalis. All gingipains 
are synthesized with an N-terminal signal peptide allowing export to the periplasm via the 
Sec pathway. Once in the periplasm, they are addressed to the cell surface by a dedicated 
complex constituted of the products of the por genes, the T9SS. The gingipains carry a C-
terminal motif, the CTD is required for recruitment to the T9SS. Transport of the gingipain 



















Figure 6: Typical P. gingivalis (W83) cells showing EDSL. (A) TEM image of several 
P. gingivalis cells. (B) TEM image of P. gingivalis cell showing IM and OM.(C) TEM 
image of P. gingivalis cell showing the presence of a thick EDSL surrounding the 
membrane of each cell, with dimension shown. Outer Membrane (OM), Inner Membrane 
(IM), Periplasm (P), Electron Dense Surface Layer (EDSL) (Electron microscope images 
provided by Arek Kulczyk, PhD, Harvard University Medical School).  
 
 
Seers et al in their study demonstrated that secretion of RgpB (member of gingipain 
family) from the periplasm across the outer membrane is dependent on the conserved CTD 
[43]. Lack of the CTD leads to the accumulation of gingipains in the periplasm itself [4, 
44] and it prevents gingipains from attaching to the outer membrane, which suggests that 
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Figure 7. Multi-domain model of the latent full-length pro-RgpB to demonstrate 
protein domains. Surface representation of the model of the latent full-length proRgpB, 
transiently present in the periplasm during secretion, including the N-terminal prodomain 
(green), the catalytic domain (purple), the IgSF domain (cyan) and the CTD (yellow) 
(Adapted from Scientific Reports | 6:23123 | DOI: 10.1038/srep23123 [37]).  
 
Presently, 12 unique genes have been found to be indispensable for secretion of CTD-
containing proteins in P. gingivalis [46]. These genes are conserved in all species bearing 
genes encoding the CTD-proteins, suggesting they are essential for assembly and/or 
functioning of T9SS [35].  Among translated products of these genes, six are predicted to 
be integral β-barrel OM proteins (PorV, PorP, PorQ, PorT, Sov and PG0543) [42], two are 
inner membrane type I proteins (PorM and PorL), while two are putative lipoproteins 
(PorK and PorW) probably anchored into the OM facing the periplasm [36, 44].  Finally, 
PorN is most likely located in the periplasm whereas PorU is found on the bacterial surface. 
In P. gingivalis, inactivation of any of these essential T9SS components leads to the arrest 
of cargo proteins in the periplasm, with the CTD still intact [47].  Apart from PorU, which 
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is the surface-located gingipain-like protease that functions as a sortase to cleave off the 
CTD from secreted proteins [43], little is known about the functional or structural role of 
other essential T9SS components [42, 47].  
Within the periodontal pathogen P. gingivalis, about 30 putative proteins bearing the 
CTD have been detected (Figure 8), including PorU and important virulence factors such 
as cysteine protease gingipains (RgpA, RgpB, and Kgp) [44], carboxypeptidase D (CPG70) 
[48], heme-binding protein (HBP35) [39], and peptidyl arginine deiminase (PPAD) [49]. 
Many of these proteins were found to be A-LPS-modified and migrated higher in SDS-
PAGE gels than their predicted molecular mass, thus, confirming their secretion and glycan 
modification via T9SS [4].  
Figure 8.   The structure-based alignment of the CTD of proteins secreted by  
P. gingivalis via T9SS (Adapted from Veith., et al, [4]). Conserved hydrophobic residues 
in β-strands are highlighted.  
Bold blue font - CTDs with experimentally determined cleavage sites 
Green bold font – cleavage sites predicted from alignment. 
L/V-F/Y-P-N-P-A/V-K/R-E/D- a sequential motif conserved in some T9SS secreted 
proteins. Thick red underlining – predicted β-strands 
KRVQTIYRNRK – predicted alpha-helixes; S1- S7 -  β-strands  
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PG_RS07070 / PG1604 (TIGR DATABASE) / PG1403 (ALAMOS DATABASE) 
is a unique CTD protein of P. gingivalis and is an essential part of the T9SS (unpublished). 
PG1604 is 776 aa protein containing a signal peptide (1-25 aa) recognized by the Sec 
system [50] and CTD domain at the C-terminus potentially cleaved by T9SS during further 
transport. In the W50 strain it is described as immunoreactive 84 kDa antigen as it was 
detected during E. coli library screening with various rat and mouse anti-P. gingivalis 
and/or periodontal patient sera [51]. The authors did not point out this protein as a good 
vaccine candidate concealing any specific details. The protein was also identified in 
proteomic analysis of P. gingivalis membrane complexes and OMV’s [52], but was not 
further characterized.  
Preliminary studies have shown that deletion of PG1604 leads to the absence of the 
secretory phenotype (white pigmented cells) (Figure 9). Heme accumulation has been 
shown previously to be dependent on the production of the CTD cargo surface protease 
Kgp in P. gingivalis [53, 54] and non-pigmentation in deletion mutant PG1604 suggests 












Figure 9.  Knockout mutant of PG1604 and a few other T9SS proteins.  
The function of PG1604 was probed by targeted mutagenesis of the protein directly in P. 
gingivalis and analyzed effect of the isogenic PG1604 gene deletion. The mutants yielded 
non-pigmented colonies indicating a failure to accumulate heme on the cell surface.  
 
Similarity searches of predicted protein tertiary structure performed with a use of 
RaptorX server revealed a matching tertiary template denoted 4A2L(PDB ID: 4A2L) of 
the BT3049 protein [55]. TB3049 is a periplasmic domain of a hybrid two- component 
system (BT4663) of Bacteroides thetaiotaomicron [55]. It possesses two β-propeller 
domains and a C-terminal Ig-like fragment (~120 residues), which is a backbone for 
homodimerization. This C-terminus is followed by kinase receptor domain anchored in the 
IM facing the cytoplasm. The 3D model of PG1604 built on the 4A2L template is 
composed of 2 consecutive β-propeller structures (1β:Q26-L311,2β; T318-F677) each 
consisting of 7 blades followed by the CTD domain of the Ig-like fold encompassing of 6 
β- strands (Figure 10), thus revealing structural similarity with BT4663. 
16 
 
β-propellers are known to provide a good platform for protein-protein interactions 
possessing a variety of functions [56]. Further studies are needed to characterize the 
structure- function and cell localization of PG1604.  
 









Figure 10. Tertiary structure prediction of PG1604 protein. The model was performed 
on RaptorX structure prediction server (http://raptorx.uchicago.edu). The most reliable 
template identified was the putative hybrid two component system BT3049 from 
Bacteroides thetaiotaomicron (PDB ID:4a2lA and 3v9fA) [55] [57]. The quality of a 
predicted 3D structure model was validated with following measures values: P-value: 
















                                                CHAPTER 2 
RESEARCH HYPOTHESIS AND SPECIFIC AIMS 
 
Research Hypothesis  
 
We hypothesize that selective modifications of the C - terminal domain of PG1604 by 
insertion of oligohistidine motives or substitution of 6 consecutive residues with 
hexahistidine, could affect the secretory phenotype of P. gingivalis.  
  
 
Specific Aims  
 
Aim 1: To probe the structure- function relationship of PG1604 by insertion and 
substitution with the oligohistidine motif in the CTD and to monitor the changes the in P. 
gingivalis secretory phenotype caused by mutations (Figure 11).  
 
Aim 2: To determine the post-translational processing and sub-cellular localization of the 









Figure 11. Schematic view of the PG1604 (PorZ) domain structure and details of 
oligohistinde insertions/substitutions. The names of P. gingivalis mutated strains are 
given on the left of each sequence. Green color represents CTDs with their cleavage site 
‘D’. HIS-tag insertions/substitutions are represented by blue color, at various sites of CTD 







Mutants at N-Terminus of CTD 




MATERIALS AND METHODS 
 
 
3.1 Bacterial strains and general bacterial culture conditions 
Wild-type strain P. gingivalis, W83 and mutant derivatives (Table 2)  
were cultured in enriched trypticase soy broth medium (eTSB: 30 g trypticase soy broth,  
5 g yeast extract, per liter, pH 7.5 and supplemented with 0.5 g L-cysteine, 5 mg hemin 
and 2 mg menadione) or on blood eTSB agar (eTSB medium + 15 g agar per liter  
and supplemented with 4% defibrinated sheep’s blood) at 37°C in an anaerobic  
chamber in an atmosphere of 90% N2, 5% CO2 and 5% H2. Escherichia coli strain  
NEB® 5-alpha (New England BioLabs DH5α derivative) was used for all plasmid 
construction work and was grown in Luria-Bertani (LB) medium and agar. For antibiotic 
selection in E. coli, ampicillin was used at 100 µg/ml and for P. gingivalis, erythromycin 
at a concentration of 5 µg/ml. A schematic summarizing the methods employed in the study 




Table 2. Bacterial strains used in the study 
P. GINGIVALIS STRAINS USED IN THIS STUDY 
STRAIN DESCRIPTION SOURCE/REFERENCE 
W83 Wild-type Reference [58] 
AT001 Insertion of 6xHIS at site Q678 in 
PG1604/ PG_RS07070 
This study 
DM007 Insertion of 6xHIS at site F677 in 
PG1604/ PG_RS07070 
Laboratory collection 
AG001 Substitution of 6xHIS at site S683 in 
PG1604/ PG_RS07070 
Laboratory collection 
AL004 Substitution of 6xHIS at site A686 in 
PG1604/ PG_RS07070 
Laboratory collection 
AL005 Insertion of 6xHIS at site L689 in 
PG1604/ PG_RS07070 
Laboratory collection 
AL006 Substitution of 6xHIS at site D690 in 
PG1604/ PG_RS07070 
Laboratory collection 
AL002 Insertion of 6xHIS at site I770 in 
PG1604/ PG_RS07070 
Laboratory collection 
DM006 Substitution of 6xHIS at site I770 in 
PG1604/ PG_RS07070 
Laboratory collection 
DM008 Insertion of 6xHIS at site R776 in 
PG1604/ PG_RS07070 
Laboratory collection 
ΔPG1604                                                        Knockout mutant-  
PG1604:: Erm 
Ky-Anh Nguyen, Australia 
 
E. COLI STRAINS USED IN THIS STUDY 
NEB 5-alpha DH5-alpha derivative; Genotype: fhuA2 
Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ)M15 gyrA96 recA1 relA1 endA1 
thi-1 hsdR17 







Table 3. Plasmids used in the study. 
Plasmid Description Source/Reference 
p1403CeB-H Master plasmid of PG_RS01060 with 
erythromycin resistant gene with 
ampicillin selection in E. coli cells and  
erythromycin selection in P. gingivalis 
cells 
Ky-Anh Nguyen, Ph.D. 
University of Sydney, 
Australia 
pAT1 Mutagenesis plasmid carrying 
insertion of 6HIS encoding tag at 
Q678 position of PG1604 
This study 
 
3.2 Analysis of growth rates of P. gingivalis mutant strains 
The growth rates of PG1604 mutants (Table 2) were compared with that of the wild-type 
strain W83 and ΔPG1604 Dilutions (1:100) of overnight bacterial cultures were inoculated 
into eTSB to reach starting OD600 0.1 and the bacteria were grown anaerobically without 
shaking at 37°C. At a time interval of 2 hours, optical density at 600 nm was determined. 
This was done over a period of 24 hours, through a direct reading in special glass tubes, 
without exposing the cultures to oxygen. A growth curve was generated by plotting the 
optical density (y-axis) versus time (x- axis). 
 
3.3 Insertion of hexa-histidine and site-directed mutagenesis of the master 
plasmid construct 
SLIM (Site-directed, Ligase- Independent Mutagenesis) PCR was carried out using 
Phusion High-Fidelity DNA polymerase (Thermo Scientific) according to 3-step protocol 
provided by the manufacturer manual (Table 4 and 5). This PCR was used to create 
insertions of the oligonucleotide motif encoding hexa-histidine into designated sites in the 
genes of interest in the master plasmids. In essence, for the mutagenesis reaction, four 
primers were designed (Table 6), adjacent to each other but have opposite orientation. One 
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pair of primers contained 5’ extension encoding for the hexa-histidine peptide. After 
specific mutation, FD DpnI (Thermo Scientific) was used to remove the non-mutated 
template.  
 
Table 4. SLIM PCR reaction mixture 
COMPONENT FOR 50μL FINAL 
CONCENTRATION 
5X Phusion HF 
Buffer 
10 μL 1X 
10Mm dNTP 2 μL 400 μM 




4 x 3 μL 250ng 4 pcs primers in one reaction: 
2 with insertion/substitution 
fragment and 2 non-tailed 
complementary to matrix DNA 
Template DNA X μL 75ng 
Phusion Polymerase 0.5 μL 0.02 U/ μL 
Distilled Water To fill up to the final reaction volume 
of  50 μL 
 
Table 5.  PCR 3 step cycling used to for mutagenesis  
STEP TIME TEMPERATURE CYCLES 
1.Initial 
DDeDDenaturation 
30 seconds 98°C 1X 
2. Denaturation 5-10 seconds 98°C 34X 
3. Annealing 10-30 seconds 68°C 34X 
4. Extension 15-30 s/kb 72°C 35X* 
5. Final Extension 10 minutes 72°C 1X 
6. Storage Hold 4°C ∞ 




















*Blue font indicates nucleotides encoding for hexa-histidine tag. 
 
3.4 Agarose gel electrophoresis 
The DNA of plasmids or PCR products were separated through agarose gel electrophoresis. 
3.4a Preparing the gel 
1. 0.8% agarose gel was made by mixing 0.8g agarose with 98 ml distilled water and 2 ml 
50X TAE buffer (final concentration 1xTAE). 
2. The mixture was heated in a microwave oven until all agarose had melted and the 
solution had started to boil. 
3. The gel solution was then left to cool (to approximately 65 °C). 
4. Midori Green Advance DNA Stain (4 μl - 6μl; Cat # MG 04) was added after the mixture 
had cooled, and gently mixed into the agarose 
5. The gel was poured slowly into a gel rack, the comb was set on one side of the gel, and 
any bubbles in the solution removed. The gel was allowed to set (15 to 20 min.). 
6. After 20 min., when the gel had solidified, the comb was removed, and the gel, together 
with the rack, was soaked into a chamber with 1X TAE gel buffer. The gel was placed with 




3.4b Loading and running the gel 
Loading buffer was added to the samples in order to visualize and sediment it in the gel 
wells. 
1. A DNA ladder (Thermo Scientific GeneRuler 1kb DNA Ladder shown in Figure 12), a 
mixture of DNA fragments of known size, was loaded along with analyzed samples. This 
was used to determine the size of the separated DNA molecule by comparing their 
migration with that of the ladder. 
2. The samples were loaded into the wells and the lid of the electrophoresis chamber was 
closed and the current was applied. The gel was run at 90-120 volts (usually 50 min.). 














3.5 Transformation of plasmid into competent E. coli NEBα cells 
Transformation into competent cells was carried out according to the manufacturer’s 
protocol and after that a few (usually 4) antibiotic-resistant colonies were picked and 
transferred to LB medium (LB agar plate as well as liquid). The plates were kept in 
incubation at 37°C and liquid media was incubated at 37°C with vigorous shaking at 225 
rpm overnight. The plates were stored at 4°C and the plasmid was extracted from the liquid 
culture using the GeneJET Plasmid Miniprep Kit. 
 
3.6 Extraction of plasmids from bacterial cells  
GeneJET Plasmid Miniprep Kit was used for efficient purification of plasmids. Steps were 
followed according to the manufacturer’s protocol. The mutated plasmids (with insertions 
of the hexa-histidine encoding sequence) were confirmed through sequencing (see 3.8).  
 
3.7 DNA concentration measurements 
Nanodrop 2000 spectrophotometer from Thermo Scientific was used to measure the DNA 
concentration.  
 
3.8 DNA Sequencing 
DNA samples (plasmids or PCR products) were sent for sequencing to The Center for 
Genetics and Molecular Medicine Sequencing Service, University of Louisville. 
Sample Preparation 
0.4 μg of clean plasmid DNA or 6ng per 100bp of PCR product in total volume of 10.4 μl 
were mixed with 1.6 μl of appropriate primer (Table 7) of 20μM stock solution.  
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Table 7. Primers used in the study for sequencing 
Primer Name Target gene Primer Sequence 
PG1604_RevHind PG1604 GACAAGCTTTGTGTCAGCGAATCACTG 
PG1604_seq_rev1 PG1604 TCCGGCTGCATTGTAGAC 
PG1604_seq_rev2 PG1604 CGAACAGACCGTTTCC 
PG1604_seq_rev3 PG1604 ATAGCTCCGGCTCAAACG 
PG1604_seq_rev4 PG1604 TTAGTTGCTCGGAGTAGG 
PG1605_seq_fwd PG1605 TGGGATCAATTGGAGAAATC 
ErmF_seq_fwd1 ermF TGGACGGACAATTAAAGC 
ErmF_seq_fwd2 ermF TTCTGGGAGGTTCCATTG 
ErmAM_seq_fwd1 ermAM TGGCGATGGAGCGGAAAC 
ErmAM_seq_fwd2 ermAM TGGATATTCACCGAACAC 
 
3.9 Generation of isogenic mutants via homologous recombination 
Insertions of DNA fragments encompassing modified genes of interest (bearing the 6xHIS 
encoding motif) into the P. gingivalis genome was performed through homologous 
recombination. Suicide plasmids containing mutated genes of interest were introduced to 
P. gingivalis cells by the electroporation. Briefly, a 40-ml mid-log-phase culture of  
P. gingivalis was harvested by centrifugation at 6,000 × g for 15 min., washed three times 
in electroporation buffer (10% glycerol [vol/vol], 1 mM MgCl2), and re-suspended in 0.5 
ml of the same buffer. All steps were carried out at 4°C. Two hundred microliters of the 
cell suspension was transferred into a pre-chilled 0.2-cm-gap width electroporation cuvette 
along with 1 μg of plasmid DNA. Electroporation was carried out at 2.5 kV and 10μF 
capacitance using a micropulser electroporation apparatus (Bio-Rad Laboratories), 
resulting in time constants of approximately 4.5 msec. After electroporation, the cells were 
allowed to recover on ice for 2 min. before the addition of 1 ml of eTSB medium to the 
suspension. Cells were allowed to grow anaerobically at 37°C overnight before being 
plated onto antibiotic selective media. Obtained mutant was named AT001 and was further 
sub cultured on selective plates, and genomic integration by a double crossover event was 
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confirmed by PCR (see section 3.11). DNA sequencing of the appropriate region of the 
genome, was used to further verify the mutant AT001 using appropriate primers (Refer 
Table 7).  
 
3.10    Chromosomal DNA isolation 
Genomic DNA from P. gingivalis AT001 mutated strain was purified using GeneJET 
Genomic DNA Purification Kit (Thermo Scientific) as described in the protocol provided 
by the manufacturer.  
 
3.11 PCR reaction to amplify the region of interest in the chromosomal DNA  
Chromosomal DNA purified from AT001 served as a template to amplify the region of 
interest – PG1604 gene, to confirm 6xHIS tag presence. Phusion High-Fidelity DNA 
polymerase, (Thermo Scientific) was used (Table 8, 9 and 10).  
 
Table 8: Reaction mixture phusion high-fidelity DNA polymerase PCR  
COMPONENT FOR 50μL FINAL 
CONCENTRATION 
5X Phusion HF 
Buffer 
10 μL 1X 
10mM dNTP 1 μL 400 μM 
AT001 DNA  1.5 μL 50 ng 
Forward Primer 
(PG1604 SallF) 
1 μL 100 μM 
Reverse Primer 
(PG1604 Rev_Hind) 
1 μL 100 μM 
Phusion Polymerase 0.5 μL 0.02 U/ μL 
Distilled Water To fill up to the final reaction volume 




Table 9. Primers used to amplify the region PG1604 in the chromosomal DNA from 
clone AT001 
 
Primer  Name Primer Sequence Purpose 
PG1604 SallF CAGGTCGACATGGAGGAAGGTATT
TGGAAATACC 
Forward primer in the 
amplification of PG1604 
PG1604_ RevHind GACAAGCTTTGTGTCAGCGAATCAC
TG 
Reverse primer in the 




Table 10.  PCR 3 step cycling used for amplification 
STEP TIME TEMPERATURE CYCLES 
1.Initial 
DDeDDenaturation 
30 seconds 98°C 1X 
2. Denaturation 5-10 seconds 98°C 34X 
3. Annealing 10-30 seconds 62°C 34X 
4. Extension 15-30 s/kb 72°C 35X* 
5. Final Extension 10 minutes 72°C 1X 
6. Storage Hold 4°C ∞ 
*Repeat from step 2 for 35 times more 
 
3.12 Gingipain activity assay  
The Gingipain activity assay was performed to quantify the secreted gingipains in the 
mutants and later compared with that of the wild type W83 and ΔPG1604. The amidolytic 
activities of Rgp and Kgp gingipains were assessed by the hydrolysis of the chromogenic 
substrates: Bz-Arg-pNA and Ac-Lys-pNA, respectively (Bachem). In a 96-well format, 
samples (in triplicates) were pre-incubated in assay buffer (200 mM Tris-HCl, 100 mM 
NaCl, 5 mM CaCl2, pH 7.6; freshly supplemented with L-cysteine to 10 mM) for 2 min. 
prior to the addition of specific substrate to the final concentration of 0.5 mM in a total 
29 
 
volume of 200 μl. The rate of formation of p-nitroanilide (pNA) was measured using 
absorbance at 405 nm every 20 s over a 10 min. period using a spectrophotometer 
(SpectraMax M5, Molecular Devices). Enzymatic analysis was performed for whole cell 
cultures adjusted to OD600 - 1.0. Equal volumes of all strains were applied (10 μl for Kgp 
and 5 μl for Rgp assay) and specific activity was measured as a function of density, and 
time per ul (mOD//min/μl). Later, total Rgp/Kgp activity in W83 wild-type strain served 
as positive control and was defined as 100%, allowing cross-comparison between 
independent experiments and statistical analysis. 
 
3.13  Cellular compartment fractionation for Porphyromonas gingivalis W83 
Subcellular localization of PG1604 protein in P. gingivalis W83 was done using the 
following protocol [59]. 
1. 15 ml of culture was grown as grown as per defined conditions (refer section 3.10). 
OD600 was adjusted to 1.5 prior to fractionation. 0.5 ml of culture sample was 
collected and 15 ml of the adjusted culture was centrifuged at 6000 x g, 15 min. at 
40 C.  
2. The cell pellet was washed once with 15 ml PBS at 40 C by re-suspension and re-
pelleting, which was re-suspended in 5ml of 0.25 M sucrose, 30mM TRIS, pH 7.6 
(solution at RT). Cells were left mixing gently for 10 min. at 40 C.  
3. Next, the cells were pelleted 12,500 x g for 15 min. at 40 C and rapidly re-suspended 
in 5 ml ice-cold dH2O. Cells were left mixing gently for 10 min. at 4
0 C.  
4. The suspension was pelleted by centrifugation at 12,500 x g for 15 min. at 40 C and 
the supernatant was designated as the periplasmic/PP sample. 
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5. The remaining spheroplasts were washes once with 15 ml PBS, pelleted at 10,000 
x g and re-suspended in 5 ml PBS and ultrasonicate for 10 x 5 second pulse (17W 
per pulse) in ice-water bath with 2 second rest between each pulse. Cellular debris 
and membranes were pelleted by ultracentrifugation at 150,000 x g for 1 hour at 40 
C. Supernatant was designated as the cytoplasmic/CP sample. 
6. The pellet was washed once with 20 ml PBS and re-suspended by first scraping 
with the sonication tip in 5 ml cold PBS. A minimum number of pulses (usually 2 
or 3 x 5 second pulses) were used to disperse the chunks and 0.5 ml of it was 
collected. Designate it as the membranes/CE sample.  
7. Cold 0.5 ml of 10% Sarkosyl (lauryl sarcosine; final concentration is 1%) was 
added and the mixture was left to mix gently for 20 min. at 40 C to dissolve the 
inner membrane or cold 0.5 ml of 10% Triton X-100 with 200 mM MgCl2 (final 
concentration: 1% Triton X-100 was added), and the mixture was left to mix gently 
for 30 min. at 40 C to dissolve the inner membrane.  
8. The Triton X-100- resistant outer membrane was pelleted by ultracentrifugation at 
150,000 x g for 1 hour at 40 C. The supernatant was designated as the inner 
membrane/IM sample and the remaining pellet was washed once with 20 ml PBS 
prior to re-suspension in 5 ml PBS by sonication as before and designated as the 







 3.14 Purification of the PG1604 from P. gingivalis AL005 mutant strain  
The growth media of the P. gingivalis mutant strain AL005 (L689 substitution 6xHistidine) 
were clarified by centrifugation at 8,000xg, 30 min. at 4°C. The pellet was re-suspended in 
cold PBS (approximately 10ml for 1liter pellet). Inhibitor TLCK (100mg -1.36 ml 
DMSO@ 200mM stock) was added to the mixture to attain final concentration of 1mM. 
The sample was then sonicated (for 1liter pellet – 1cycle ; 10 pulses ; 3sec ; 30 - 40% 
power ; 17- 20 watts). The sonicated sample was centrifuged at 150000xg for 1hr at 4°C. 
The clarified sample was dialyzed against 4 liters of the Binding buffer (20mM sodium 
phosphate, 500mM sodium chloride, 20mM Imidazole, 0.02% sodium azide; pH – 7.4). 
The purification column containing Ni Sepharose 6Fast Flow (GE Healthcare) was 
equilibrated with the Binding buffer before loading a sample.  After extensive washing with 
Binding buffer, protein fraction bound to the matrix was eluted with Elution buffer (20 mM 
sodium phosphate, 0.5 M sodium chloride, 500 mM imidazole; pH 7.4). Obtained eluate 
was concentrated by ultrafiltration and the purified sample was further analyzed by 
western-blot.   
 
3.15  Western- Blot 
3.15a Sample preparation: 
P. gingivalis W83 and mutant strains (Table 2) were anaerobically grown until OD600 1.5-
2.0. 1.5ml of culture subjected to centrifugation at 6,000xg, 15 min. at 4°C and the cells 
was suspended in 280 µl of PBS (reaching a final volume of approx. 315 µl). Cell were 
incubated with 35µl TLCK (original concentration 200mM) at RT for 10 min. and 
sonicated (5 pulses; 3sec; 30 - 40% power; 17- 20 watts). Then 50 µl NuPAGE LDS 
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loading buffer was added, heated at 100°C for 5 min., finally 50 µl NuPAGE LDS loading 
buffer with 10% BME was added, heated at 100°C for another 10 min.  
 
3.15b   Electrophoresis and transfer of proteins 
Total 30-50 µl of P. gingivalis whole cell lysates (250 μg of lysate loaded) or purified 
AL005 concentrate fraction were electrophoresed by using 4-12% Bis-Tris SDS-PAGE 
(Invitrogen) or Novex® 10-20% Tricine Gel (Invitrogen) at 120 volts for 90 min. 
Subsequently, proteins were transferred onto nitrocellulose (BioRad) at 100 volts for 60 
min. (wet transfer), and then blocked with SuperBlock™ (PBS) Blocking Buffer 
(Thermo Scientific) for 2h. The membranes were probed with appropriate primary and 













Figure 13. Standard used western-blot analysis: (A)Precision Plus Protein™ Kaleidoscope™ 




 Antibodies used to detect RgpB and Kgp:  
Primary antibodies: anti-Kgp (7B9.F10.F6); 1:250 and anti-RgpB monoclonal 
(Mouse; 18E6.F7 IgGI); 1:250; Secondary antibodies: anti-mouse (Bio Legend 
405306); 1: 5000 
 Antibodies used to detect histidine tags and PG1604  
Primary antibodies: anti-HIS monoclonal (Mouse; BD552565); 1:2000 and anti-
PG1604 polyclonal (Mouse); 2µg; Secondary antibodies: anti-mouse (Bio Legend 
405306); 1: 5000 
 
3.15c Visualization of transferred proteins 
Membranes were developed using chemiluminescent substrate for HRP – horseradish 
peroxidase (Thermo Scientific Super Signal West Pico Cat # 34080) at 30 second exposure 






































The P. gingivalis W83 mutant strain expressing the HIS-tag modified PG1604 
protein was generated through double crossover recombination with the constructed 
suicide plasmid. The plasmid was created using the SLIM PCR method using DNA of the 
master plasmid - p1403CeB-H as a template (see point 4.1 below) the final plasmid was 
introduced into P. gingivalis cells via electroporation. The mutated P. gingivalis strain was 
then used to analyze the phenotype together with other HIS-tagged mutants available as a 
laboratory collection (created in analogous manner) The wild-type W83 and knock-out 
(1604) strains were used as positive and negative controls, respectively. Details of all 
results are presented below. 
4.1 Construction of Master Plasmid, p1403CeB-H  
The master plasmid p1403CeB-H (7947 bps) was provided by Dr. Ky-Anh 
(Institute of Dental Research, Westmead Centre for Oral Health and Westmead Millenium 
Institute, Sydney, Australia). It is pUC19 derivative (E. coli vector) which was created by 
sequential cloning of 3 DNA fragments: a full coding region of the PG1604 gene, followed 
by the erythromycin resistance cassette (ermF ermAM genes) and a fragment of the  
downstream PG1605 gene. Its construction was confirmed by sequencing. A schematic 





Figure 15. Schematic view of the master plasmid p1403CeB-H.  
Blue – E.  coli origin of replication; Gray – bla gene, E. coli ampicillin selection marker; 
Red- full coding region of PG1604 gene and fragment of downstream PG1605 gene; 
Green- erythromycin resistance cassette (ermF ermAM genes). Selected restriction 







4.2 Insertion of hexa-histidine and site-directed mutagenesis of the master 
plasmid p1403CeB-H 
Phusion SLIM (Site-directed, Ligase- Independent Mutagenesis) PCR (refer 
Materials and Methods 3.3) was employed for hexa-histidine insertion at the position Q678 
of C-terminal domain of PG1604 (Figures 16 &17)  
 
Figure 16. A fragment of PG1604 sequence with 6xHIS insertion at the position Q678 





Figure 17. A fragment of the master plasmid p1403CeB-H sequence, representing the 
region of 6xHIS insertion at the position Q678 (marked with red) in PG1604. Primers 
used for mutagenesis and sequencing are highlighted in yellow. Amino acid sequence of 










E. coli cells were transformed with the created plasmid and clones were selected on 
LB agar plates containing ampicillin. Plasmid DNA was isolated from several colonies and 
screened for the correct mutation by DNA sequencing of the pertinent region (Figure 18) 
followed by full plasmid sequencing of the HIS-tagged clone. The correct plasmid was 
named/denoted pAT1. 
   
 
Figure 18. Alignment of the p1403CeB-H master plasmid sequence vs. pAT1 (a 
fragment).  
The results obtained from sequencing being compared to wild-type fragment of PG1604 
present in the master plasmid (p1403Che eB-H). Insertion of fragment encoding for 6xHIS 
(CATCACCATCACCATCAC) in the pAT1 is not highlighted. 
   
4.3 Generation of isogenic mutant via homologous recombination 
Double cross-over recombination between the mutated suicide plasmid (pAT1) and 
the W83 P. gingivalis chromosome was achieved by the electroporation method. Clone 
obtained on selective erythromycin plates was named AT001 and was checked for proper 
genomic modification by PCR followed by DNA sequencing.  
In the similar way as described above, 5 other mutants at a N-terminus of the CTD 
(DM007, AG001, AL004, AL005, AL006) and 3 mutants at a C-terminus (AL002, 
DM006, DM008) were created by insertion/substitution of histidine tags at different 










Figure 19. Mutants generated by insertion/substitution of oligohistidines at the C-
terminal  
domain region of PG1604. The names of P. gingivalis mutated strains are given on the 
left of each sequence. Green color represents the CTDs with their cleavage site ‘D’. HIS-
tag insertions/substitutions are represented by blue color, at various sites of CTD indicated 
by red color. 
 
 
4.4 Assessment of the mutant strains on the blood agar plates 
P. gingivalis W83, ΔPG1604 and all 9 HIS-tagged mutants were streaked on blood agar 
plates. Wild-type dark/black pigmentation was observed for most of the strains except for 
ΔPG1604, DM006 and AL005 which yielded white-pigmented colonies on the blood 
agar. AL005 turned dark with time, but hemolysis (which accompanies normal growth) 




Figure 20. P. gingivalis mutants streaked on blood agar plates.  
(A) Mutants on the 3rd day of culture with white growth observed for ΔPG1604, DM006 
and AL005. (B) The 8th day of culture when all but ΔPG1604, DM006 and AL005 strains 
are showing hemolysis.  
 
4.5 Analysis of growth rates of P. gingivalis mutant strains 
The growth rates of 9 HIS-tagged mutants were compared with that of the wild-
type W83 and ΔPG1604. A growth curve was generated by plotting the optical density (y-
axis) versus time (x- axis) at an interval of 2 hours over 24 hours. The growth pattern of 
the mutants was not much different than that of the wild-type strain W83 except that a 
delayed exponential phase seen in ΔPG1604, DM006, DM007 and DM008 (Figure 21). 
Doubling times were calculated from the growth curves for three density points (OD600: 







Figure 21. Growth curve of P. gingivalis ΔPG1604 and strains producing HIS-tagged 
PG1604. X-axis represents the time in hours and the Y-axis represents the optical density 
at 600nm taken at 2 hour interval over 24 hours. Dilutions (1:100) of overnight bacterial 
cultures were inoculated into eTSB to reach starting OD600 0.1 and the bacteria were grown 
anaerobically without shaking at 37°C. Wild-type W83 was used as positive control. 
 
 
4.6 Effect of oligohistidine modification of PG1604 on gingipain activity and 
protein processing of the mutant strains 
The Gingipain activity assay was performed to quantify the secreted gingipains 
(Kgp and RgpA/B) in the mutants and compared with that of the wild-type W83 and 
ΔPG1604. t-test was used to assess whether the means of two group 
are statistically different from each other using the p-value. A varied gingipain activity, 
both Kgp and Rgp, were observed in the mutants (Figure 22C).  
Hexa-histidine insertions after Phe677 (mutant DM007) or Arg776 (mutant DM008) 
only slightly decreased the level of gingipains activity, but insertion after Gln678 (mutant 
AT001) caused Rgp gingipain activity to drop to 35% and Kgp to 80% of wild-type.  On 
the other hand, substitution of 6 residues after Ser683
 (mutant AG001) and Ala686
 (mutant 
AL004) with the hexahistidine motif had little effect on gingipain secretion. In contrast, 
PG1604 mutants at N- terminus of CTD PG1604 mutants at C- terminus of CTD 
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the substitution of residues after Leu689 (mutant AL005)
 nearly abolished gingipain 
activity. Even more dramatic effect was exerted by substitution of the 6 C-terminal residues 
I770RFAVIR with histidines (mutant DM006), which totally obliterated both gingipains 
activities of the mutant (Figure 22C).  In contrast, hexahistidine insertion after Ile770 
(mutant AL002) did not affect gingipain activity. 
Western-blot analysis for the PG1604 mutants was done using specific monoclonal 
antibodies against of Kgp, Rgp and the results correlated with that of the gingipain activity 
assay (Figure 22B). 
Gingipains are normally expressed with a large N-terminal propeptide, followed by 
the catalytic protease domain (circa 50 kDa) and hemagglutinin/adhesin domains (except 
RgpB) and finally the CTD at the C-terminus. During maturation, the nascent polypeptides 
are proteolytically processed so that only the catalytic and hemagglutinin/adhesin domains 
remain as a non-covalently associated complex and are secreted onto the cell surface [60]. 
The released gingipains are additionally modified by the covalent attachment of A-LPS, 
which in the case of RgpB, is attached directly to the catalytic domain to result in an 
increase of its molecular mass from 50 kDa to 70-90 kDa. This membrane anchored form 
of RgpB is referred to as membrane-type RgpB (Mt-RgpB) [60]. mt-RgpB is clearly visible 
in P. gingivalis mutants which showed Rgp activity close to that of the wild-type (DM007, 
AG001, AL004, AL006, AL002 and DM008). AT001 mutant with lowered Rgp activity 
(35% of the parental wild-type strain) also possesses significant amounts of mt-RgpB.  
Conversely, mutants DM006 and AL005 devoid of enzymatic activities showed the full-
length pro-RgpB accompanied by forms with partially and fully cleaved N-terminal 
profragment similar to that observed in ΔPG1604 (Figure 22B). Analogous processing 
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results were observed for Kgp. Interestingly, minute activity of Kgp in AL005 mutant (13% 
of the parental wild-type strain) was sufficient for this strain to attain some processed Kgp 
(50 kDa) although much less pronounced than the unprocessed variant (150 kDa).  This is 
in contrast to ΔPG1604 and DM006, which present only unprocessed Kgp (Figure 22B). 
To better understand the effect of substitutions/insertions on PG1604 localization and 
processing, the mutants were analyzed by western-blot with antibodies specific for PG1604 
and the polyhistidine sequential motif.  As presented in Figure 22B, a band immunoreactive 
with anti-PG1604 antibody was clearly visible in all strains except ΔPG1604. Interestingly, 
two strains (AL004 and AL002) with normal/unaltered gingipain activity, exhibit an extra 
band at the lower molecular mass of ~70 kDa that is reactive to anti-PG1604 Abs. This 
band was the only PG1604-immunoreactive band present in the strains devoid of or low in 
the gingipains activity (mutants AL005 and DM006) (Figure 221B).  
Western-blotting with anti-polyhistidine antibodies revealed the presence of the tag 
in all mutants expressing tagged-PG1604 in the loop preceding the CTD (Figure 22B left 
panel). However, in the case of the C-terminal mutants, the tag was detected in P. gingivalis 
expressing the C-terminally labeled PG1604 (DM008) (Figure 22B, right panel). The 70 
kDa band did not react with anti-polyhistidine antibodies, suggesting that mutated PG1604 
was cleaved at the C-terminus losing circa 10 kDa. In the context of an apparent C-terminal 
truncation of C-terminally modified PG1604, it is important to reiterate that in the AL005 
mutant the 70 kDa form of PG1604 still reacted with anti-polyhistidine antibody as the tag 






Figure 22. Effect of PG1604 modification at the C-terminus and in a loop preceding 
the CTD on T9SS function. (A) Location of insertions and substitutions of consecutive 
residues by hexahistidine in the PG1604 polypeptide chain. Wild-type and mutant strains 
were grown to stationary phase and diluted equally to OD600 = 1.0 then whole cultures were 
subjected (B) to western-blot analysis for PG1604, oligohistidine, RgpB and Kgp, and (C) 












4.7 Subcellular localization of PG1604 protein in the P. gingivalis W83 
Using the proteomics approach, PG1604 has been identified in the outer membrane 
[4] and outer membrane vesicles (OMV) [52] of P. gingivalis.  To confirm the suggested 
location of the protein, we performed WB on cultures quantitatively separated into whole 
cells and subcellular fractions, including the cell envelope (IM+OM), IM, OM, OMV, 
particle-free medium, periplasm and cytoplasm. Majority of PG1604 was found associated 















Figure 23. Cellular fractions extracted from W83 reacted to PG1604 specific mouse 
pAbs. P. gingivalis cells were quantitatively fractionated into whole cell extract (WC), 
periplasm (PP), cytoplasm (CP), cell envelope (CE), outer membrane (OM) and inner 
membrane (IM). Samples were electrophoresed by using Novex® 10-20% Tricine Gel 
(Invitrogen) at 125volts for 90 min. Subsequently proteins were transferred onto 
nitrocellulose (Bio-Rad) at 100 volts for 60 min. PG1604 was detected using PG1604 








4.8  Purification of PG1604 from the P. gingivalis AL005 mutant strain 
To obtain larger amounts of truncated PG1604 version (70 kDa) for further 
analysis, 0.5 liter of the AL005 (L689 substitution 6xHistidine) mutant culture was 
cultivated to OD600 ~ 1.35-1.85 and processed to obtain a sample enriched in our 
protein of interest (Refer section 3.14) with a use of Ni-Sepharose. HIS-tagged 
proteins bound to the resin were eluted in a single step with 500 mM imidazole. 
Thereafter, eluates were concentrated (100x) and total 50 µl of purified, concentrated 
fraction (0.8 μg/μl concentration) was analyzed by western-blot. Analysis of the 
purified AL005 mutant revealed a single band at approximately 70kDa 








Figure 24. Western-blot analysis of the purified mutant AL005 (L689 
substitution 6xHistidine) of PG1604. Total 50 µl of concentrated fraction of AL005 
eluted from Ni-sepharose (0.8 μg/μl) and the pure recombinant PG1604 protein 
(80ng) were electrophoresed by using 4-12% Bis-Tris SDS-PAGE (Invitrogen) at 
150 volts for 60 min. Subsequently proteins were transferred onto nitrocellulose (Bio-
Rad) at 100 volts for 60 min. PG1604 was detected using PG1604 polyclonal 
(Mouse), 2µg. 
 







 CHAPTER 5 
DISCUSSION 
 
The newly discovered T9SS system used by bacterial species belonging to the 
Bacteroidete phylum to secrete proteins or assembly of a gliding-motility apparatus seems 
to be more complicated than other known secretion systems of Gram-negative bacteria.  
T9SS is composed of at least 12 essential proteins, including PG1604 a subject of this 
thesis.  As in the case of any other essential components, depletion of P. gingivalis of the 
PG1604 function, either through deletion of the PG1604 gene or limited site-directed 
mutations within the sequence preceding the IgSF-like C-terminal domain (AL005 mutated 
strain) and at the C-terminus of the protein (DM006), disabled the secretion of CTD-
bearing cargo proteins (e.g. Kgp and Rgp) which accumulated in the unprocessed (Figure 
22B) and inactive forms (Figure 2C) in the periplasm.  
The outer membrane (OM) localization of the PG1604 protein shown through cell 
fractionation (Figure 23) was further supported by cell surface attachment analysis (FACS, 
unpublished laboratory data), thus confirming that PG1604 is not only a functional 
component of T9SS, but is also transported outside alike other cargo proteins. However, 
the unusual feature of PG1604, as the protein indispensable for the T9SS secretory activity 
and, in the same time the T9SS cargo protein, is its presence in a full-length polypeptide 
together with the CTD (80 kDa).  Clearly, the CTD of PG1604 is not cleaved during the 
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protein translocation to the surface, as in the case of the other T9SS substrates [44]. This 
observation is concluded from western-blot analysis performed with anti-PG1604 serum  
on cell lysates of the wild-type P. gingivalis (Figure 22B) as well as by using anti-HIS 
antibodies and detecting PG1604 at 80 kDa in DM008 strain expressing the protein with 
octahistidine tag at the C-terminus after the last amino acid, R776 (Figure 22B).  
Translocation of cargo proteins across the OM by T9SS is associated with CTD 
cleavage by PorU and simultaneous attachment of A-LPS [36]. Synchronization of these 
two events apparently depends on the length of a loop between the CTD and a preceding 
domain of a secreted protein.  Insertions at and upstream the cleavage site uncoupled 
proteolytic cleavage of CTD from A-LPS attachment and proteins modified in this way 
were released into the medium in non-glycosylated form [61].  In contrast, downstream 
insertions or amino acid substitutions within the linker region have little effect on the cargo 
protein cleavage, modification and attachment to the cell surface, at least in the case of 
RgpB [62]. In the case of PPAD and RgpB, the domain preceding CTD has the 
immunoglobulin-like fold [45].  Similarly folded domains comprising of 6-8 -strands 
preceding the CTD, are predicted with high confidence in 22 out of 29 remaining T9SS 
cargo proteins. In these proteins, the cleavage sites by the PorU sortase, either 
experimentally determined or predicted, are located 2-6 residues downstream of the last -
strand.  Such consensus cleavage site seems to be missing in PG1604. For now, the mode 
of further processing after the transport of PG1604 (e.g. attachment of the OM) is unknown.  
The tertiary structure of RgpB- and PG1604-derived CTDs is well conserved, but it 
is strikingly similar when limited to the last two -strands, which superimpose almost 
perfectly despite sharing only limited amino acid sequence identity (Potempa et al., 
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unpublished results). Taking into account that the signal for OM translocation, cleavage of 
the CTD and A-LPS attachment is located in these two last -strands [63], this observation 
strongly supports a contention that their structure, rather than a specific sequential motif is 
essential for recognition of the signal, apparently in the structural context of the preceding 
domain.  Therefore, mutations of the interdomain linker of PG1604 by the insertion of the 
oligohistidine or replacement of consecutive residues with this motif, which do not affect 
the structure of the adjacent domains, do not affect function of PG1604 (DM007, AG001, 
AT001, AL004, AL006, AL002. DM008) as judged by strain pigmentation (Figure 20), 
full gingipain processing (Figure 22B) and gingipains activity (Figure 22C).  Similarly, 
several HIS residues can be added to the C-terminus without any effect on P. gingivalis 
secretory phenotype (DM008 strain). In stark contrast, however, substitution of the last 6 
residues with hexahistidine (DM006) apparently rendered PG1604 susceptible for limited 
proteolysis at the C-terminus, leading to the truncated protein devoid of its essential 
function in T9SS.  Interestingly, insertion of 6xHis in the middle of the last -strand did 
not affect PG1604 translocation to the surface and its function in the CTD-protein secretion 
(AL002).  Most likely such modification does not destroy the structure of the CTD.  
To conclude, the results obtained in this study support that the CTD of PG1604 
protein is not cleaved off upon its transport through T9SS, as shown by western-blot with 
anti-PG1604 serum (migration at full length ~80 kDa) and anti-HIS mAb for HIS-tagged 
mutant at the C-terminus (P. gingivalis strain DM008). The selective modifications of the 
PG1604 protein, alter the proper maturation of secreted virulence factors (Kgp and Rgp) 
and due to disruption of the function of T9SS of P. gingivalis. This finding enable us to 
conclude that PG1604 is a novel functional component of T9SS located mainly in the outer 
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membrane. Moreover, its CTD is not only essential for its transport through T9SS but also 
necessary for further physiological functions. Therefore, following the T9SS 
nomenclature, we designate the PG1604 protein as PorZ. The present study contributes to 
understanding of the mechanism of recognition and processing of CTD bearing cargo 
proteins that may provide a significant opportunity to impede maturation of these important 
virulence factors in the treatment of periodontal disease. 
Further studies are needed to determine the functional role of the PG1604 in the 
T9SS by solving its crystal structure and also, to demonstrate how PG1604 interact with 
other CTD class proteins of T9SS. This conclusion can be extended on other periodontal 
pathogens such as P. intermedia and T. forsythia, which also secrete CTD bearing proteins 
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BCA-    bicinchoninic acid  
bp -       base pair  
CTD-    C-terminal domain 
dH2O - distilled water 
DNA -  deoxyribonucleic acid  
e.g. -     exempli gratia (for example)  
etc -      et cetera (and other things)  
g -         gram or gravitational force (acceleration)  
kb -       kilobase pair  
M -        molar concentration  
mA -     milliampère  
mg –     milligram 
min -     minutes 
            mL -     milliliter  
ng -       nanogram  
PBS-     phosphate-buffered saline  
Pg-        Porphromonas gingivalis 
           TLCK-   tosyl-L-lysyl-chloromethane hydrochloride 
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µg -        microgram  
µL -       microliter  
 
 
B) Doubling times were calculated from the growth curves for three density points 










CONTROL W83 6.8 232 ±21 
 Δ1604* 12.0 260 ±25 
PG1604 




DM007  F677ins 14.1 274 ±21 
AT001 Q678ins 9.4 322 ±29 
AG001 S683sub 9.4 232 ±21 
AL004  A686sub 8.8 218 ±17 
AL005  L689sub* 8.1 218 ±17 
AL006  D690ins 8.8 210 ±17 
PG1604 




AL002 I770ins 8.9 213 ±21 
DM006  I770sub* 13.4 305 ±29 
DM008  R776ins 11.0 207 
±21 
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LOS ANGELES, CA                 03/2016 
 
UPENN- PENN PERIODONTAL CONFERENCE                                                  




IDA COLGATE FUTURE DENTAL PROFESSIONAL PROGRAM                     
BANGALORE, INDIA              05/2012 
 
IDA COLGATE FUTURE DENTAL PROFESSIONAL PROGRAM                      
BANGALORE, INDIA              05/2011 
 
NATIONAL B.D.S SEMINAR IN ORAL MEDICINE AND RADIOLOGY           




ACADEMIC AWARDS AND NOMINATIONS 
 Summer Research Scholarship, from University of Louisville School of 
Dentistry, 2016 and 2015 
 
 School of Interdisciplinary and Graduate Studies- Oral Biology program tuition 
scholarship award, 2016 and 2015 
 
 Graduate Student Council travel award, University of Louisville, 2016 
 
 Graduate Merit Scholarship, University of Louisville 2016 
 
 Best Outgoing Student 2007- 2012 award from M.S. Ramaiah Dental College.  
 
 Public health dentistry, General Surgery and Oral Pathology and Microbiology 
Subject Topper Awards. 
 
 Awarded Certificates of Merit for being the topper in all the 4 years of Bachelor 
of Dental Surgery, 2007- 2012, M.S.Ramaiah Dental College. 
 
 IDA Scholarship for the year 2009-2010 for being the topper of the class. 
 
 Nominated for the Pierre Fauchard Academy UG Student Certificate of Merit 
Award 2012, from M.S. Ramaiah Dental College. 
 
 Nominated for the Indian Association of Public Health Dentistry (IAPHD)’s 
subject topper award for the year 2010 from the Department of Public Health 
Dentistry, M.S. Ramaiah Dental College. 
 
 
 
 
